Delivery Order SPE2DB20D3101-SPE2DB25FRPB9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,047.69 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone treatment. The contract is a firm fixed price delivery order with an ultimate completion date of August 28, 2025, issued on August 27, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award carries no set-aside designation and was competitively awarded to the prime...
- The Defense Logistics Agency awarded a delivery order valued at $1,396.86 to AmerisourceBergen Drug Corp for Norditropin FlexPro 10 mg/1.5 mL, a human growth hormone medication. This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of June 6, 2025. The award was issued on June 5, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,857.62 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 ml, a human growth hormone medication. The contract, awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,917.35 to AmerisourceBergen Drug Corp for Norditropin FlexPro 10 mg/1.5 mL, a human growth hormone therapeutic product. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the prime contractor for this pharmaceutical supply delivery. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,971.47 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone medication. The contract, awarded on August 12, 2025, with completion targeted for August 13, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, executed this order through its Corporate Office division. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone medication. This firm fixed-price delivery order, valued at $6,984.60, is scheduled for completion by September 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively granted with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Norditropin Flexpro 10 mg/1.5 ml, a human growth hormone medication, valued at $5,005.52 with a firm fixed price structure. The delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 23, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,793.84 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone medication used to treat growth disorders and related conditions. This competitively awarded, firm fixed price delivery order is scheduled for completion by September 30, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract contains no set-aside designation,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $6,773.84 to AmerisourceBergen Drug Corp for Norditropin FlexPro 10 mg/1.5 mL, a human growth hormone therapeutic. The contract, issued on June 2, 2025, with an ultimate completion date of June 3, 2025, represents a firm fixed price delivery under a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled this order from its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,354.52 to AmerisourceBergen Drug Corp for Norditropin Flexpro 10 mg/1.5 mL, a human growth hormone medication. The award, issued on September 16, 2025, with an ultimate completion date of September 17, 2025, represents a firm fixed-price, non-set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location in the same jurisdiction. This...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRPB9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,197.90 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone injectable medication. This firm fixed-price delivery order was issued on June 30, 2025, with an ultimate completion date of July 1, 2025, and represents a non-competitive award executed under an existing contract vehicle. The product will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that provides comprehensive pharmaceutical support for military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen supplies a broad range of medical products including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains to support the Defense Health Agency and other government healthcare systems. The company's extensive contract portfolio with DLA demonstrates its established capability to meet federal medical procurement requirements through both competitive and streamlined delivery order processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 6/30/25 |